Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2026)

Lucid Diagnostics filings provide 3 years of Total Non-Current Liabilities readings, the most recent being $5.5 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 18.07% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 million, a 18.07% decrease, with the full-year FY2025 number at $5.5 million, down 18.07% from a year prior.
  • Total Non-Current Liabilities hit $5.5 million in Q4 2025 for Lucid Diagnostics, down from $6.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $6.7 million in Q4 2024 to a low of $1.3 million in Q2 2022.
  • Median Total Non-Current Liabilities over the past 3 years was $3.5 million (2022), compared with a mean of $3.7 million.
  • The widest YoY moves for Total Non-Current Liabilities: up 18.07% in 2025, down 18.07% in 2025.
  • Lucid Diagnostics' Total Non-Current Liabilities stood at $1.3 million in 2022, then surged by 424.49% to $6.7 million in 2024, then decreased by 18.07% to $5.5 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $5.5 million (Q4 2025), $6.7 million (Q4 2024), and $1.3 million (Q2 2022) per Business Quant data.